Management of acute myocarditis and chronic inflammatory cardiomyopathy: an expert consensus document

E Ammirati, M Frigerio, ED Adler, C Basso… - Circulation: Heart …, 2020 - Am Heart Assoc
Myocarditis is an inflammatory disease of the heart that may occur because of infections,
immune system activation, or exposure to drugs. The diagnosis of myocarditis has changed …

Challenges in Cardiac and Pulmonary Sarcoidosis: JACC State-of-the-Art Review

MG Trivieri, P Spagnolo, D Birnie, P Liu… - Journal of the American …, 2020 - jacc.org
Sarcoidosis is a complex disease with heterogeneous clinical presentations that can affect
virtually any organ. Although the lung is typically the most common organ involved …

[HTML][HTML] Acute myocarditis: aetiology, diagnosis and management

T Lampejo, SM Durkin, N Bhatt, O Guttmann - Clinical Medicine, 2021 - Elsevier
Acute myocarditis is a serious, likely underdiagnosed condition affecting people of all ages
and for which the number of UK hospital admissions is rising. A primary diagnosis of …

Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis

J Lehtonen, V Uusitalo, P Pöyhönen… - European heart …, 2023 - academic.oup.com
Cardiac sarcoidosis (CS) results from epithelioid cell granulomas infiltrating the myocardium
and predisposing to conduction disturbances, ventricular tachyarrhythmias, and heart …

FDG-PET/CT (A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group …

RHJA Slart… - European journal of …, 2018 - Springer
Large vessel vasculitis (LVV) is defined as a disease mainly affecting the large arteries, with
two major variants, Takayasu arteritis (TA) and giant cell arteritis (GCA). GCA often coexists …

[HTML][HTML] Clinical manifestations, diagnosis, and treatment of sarcoidosis

P Ungprasert, JH Ryu, EL Matteson - Mayo Clinic Proceedings: Innovations …, 2019 - Elsevier
The focus of this review is current knowledge about the epidemiology, clinical
manifestations, diagnosis, and treatment of both pulmonary sarcoidosis and extrapulmonary …

Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis

W Damsky, A Wang, DJ Kim, BD Young, K Singh… - Nature …, 2022 - nature.com
Sarcoidosis is an idiopathic inflammatory disorder that is commonly treated with
glucocorticoids. An imprecise understanding of the immunologic changes underlying …

Myocardial tissue characterization and fibrosis by imaging

TD Karamitsos, A Arvanitaki, H Karvounis… - Cardiovascular …, 2020 - jacc.org
Myocardial fibrosis, either focal or diffuse, is a common feature of many cardiac diseases
and is associated with a poor prognosis for major adverse cardiovascular events. Although …

Assessment of Myocardial 18F-FDG Uptake at PET/CT in Asymptomatic SARS-CoV-2–vaccinated and Nonvaccinated Patients

T Nakahara, Y Iwabuchi, R Miyazawa, K Tonda… - Radiology, 2023 - pubs.rsna.org
Background Patients who developed myocarditis after SARS-CoV-2 vaccination show
abnormalities on cardiac MRI scans. However, whether myocardial changes occur in …

Update on acute myocarditis

E Ammirati, G Veronese, M Bottiroli, DW Wang… - Trends in cardiovascular …, 2021 - Elsevier
Acute myocarditis (AM), a recent-onset inflammation of the heart, has heterogeneous clinical
presentations, varying from minor symptoms to high-risk cardiac conditions with severe heart …